Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Mechanical circulatory support devices for acute right ventricular failure
Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure